Research Advancing Kentucky: Predicting and preventing heart attacks, strokes
Researchers at the University of Kentucky play an important role in advancing the health, well-being and future of our Commonwealth.
Much of that work is done with support from the National Institutes of Health (NIH). That support allows our researchers to find answers to many of the critical health issues facing Kentuckians.
Vincent Venditto, Ph.D., is supported by the National Heart, Lung, and Blood Institute, the National Institute of Neurological Disorders and Stroke and the National Institute of General Medical Sciences. He is also an associate professor of pharmaceutical sciences at the UK College of Pharmacy.
Venditto’s NIH-funded research has identified a cardiovascular biomarker that helps predicts risk of heart attack or stroke. His personal connection to the impact of his father’s heart attack on his family has driven this work.
His research also bridges organic chemistry, immunology and vaccine development to harness the immune system for disease treatment and prevention, with a strong emphasis on translational science and community impact.
“UK is a collaborative and dynamic place to work and do research that I hope will continue to grow,” said Venditto. “Research funding provides a foundation for major discoveries that not only impact patients but also become an economic driver for the Commonwealth. As the university’s research expands, there is a significant opportunity to build a robust biotech ecosystem that harnesses the foundation established by UK to encourage biotech and pharma to find their homes in Kentucky and establish new jobs to benefit the Commonwealth.”
Venditto and other members of the research community shared the importance of NIH-funded research at UK in this video series from Research Communications.
Learn more about each featured researcher.
Research in the news:
